Causal Graph Neural Networks for Healthcare

Munib Mesinovic, Max Buhlan, Tingting Zhu · 2025

Read Causal Graph Neural Networks for Healthcare by Munib Mesinovic, Max Buhlan, Tingting Zhu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2511-02531.txt.

Introduction

Munib Mesinovic, Max Buhlan, and Tingting Zhu survey a family of medical AI methods that try to learn causes rather than correlations. Hospital AI often degrades when moved between hospitals and can inherit biased patterns from its training data, partly because it learns statistical associations instead of causes. Causal graph neural networks combine graph views of biomedical data with causal inference, aiming at the mechanisms that stay invariant underneath.

The review covers structural causal models, disentangled causal features, and interventional and counterfactual reasoning on graphs. Applications discussed include psychiatric diagnosis from brain networks, cancer subtyping from multi-omics data, continuous monitoring of body signals, and drug advice, all feeding toward patient-specific causal digital twins. The authors are frank about obstacles: computing cost, checking beyond usual cross-checks, and causal-washing, where causal language is worn without causal evidence. A tiered framework separates causal-flavoured designs from validated causal discoveries.

Catalog record

CREATORMunib Mesinovic, Max Buhlan, Tingting Zhu
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE101 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2511-02531

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Causal Graph Neural Networks for Healthcare Munib Mesinovic, Max Buhlan, Tingting Zhu Abstract Healthcare artificial intelligence systems routinely fail when deployed across institutions, with documented performance drops and perpetuation of discriminatory patterns embedded in historical data. This brittleness stems, in part, from learning statistical associations rather than causal mechanisms. Causal graph neural networks address this triple crisis of distribution shift, discrimination, and inscrutability by combining graph-based representations of biomedical data with causal inference principles to learn invariant mechanisms rather than spurious correlations. This Review examines methodological foundations spanning structural causal models, disentangled causal representation learning, and techniques for interventional prediction and counterfactual reasoning on graphs. We analyse applications demonstrating clinical value across psychiatric diagnosis through brain network analysis, cancer subtyping via multi-omics causal integration, continuous physiological monitoring with mechanistic interpretation, and drug recommendation correcting prescription bias. These advances establish foundations for patient-specific Causal Digital Twins, enabling in silico clinical experimentation, with integration of large language models for hypothesis generation and causal graph neural networks for mechanistic validation. Substantial barriers remain, including computational requirements precluding real-time deployment, validation challenges demanding multi-modal evidence triangulation beyond cross-validation, and risks of causal-washing where methods employ causal terminology without rigorous evidentiary support. We propose tiered frameworks distinguishing causally-inspired architectures from causally-validated discoveries and identify critical research priorities, including hierarchical causal discovery exploiting biological modularity, integration of diverse data modalities, and regulatory pathways for systems making causal rather than purely associational claims. Success requires balancing theoretical ambition with empirical humility, computational sophistication with clinical interpretability, and transformative vision with uncompromising validation standards. keywords causality, graphs, healthcare, interpretability, machine learning, time-series 1 Introduction In 2019, a widely deployed risk prediction algorithm for the allocation of healthcare resources systematically underestimated the severity of the disease for Black patients by relying on healthcare costs as a proxy for health needs, despite Black patients receiving less aggressive treatment even when experiencing an equivalent burden of disease, resulting in discrimination affecting millions of patients annually Obermeyer_2019_Dissecting . That same year, a diabetic retinopathy screening system that achieved 94% accuracy in one hospital dropped to 73% in another, having learnt site-specific correlations, perhaps scanner characteristics or local clinical protocols, rather than causal disease mechanisms Beede_2020_Human . These failures exemplify the triple crisis of AI in healthcare: models collapse under distribution shift, perpetuate discriminatory patterns embedded in historical data, and struggle to provide reliable mechanistic insight that clinicians can verify Futoma_2020_Myth ; Zech_2018_Confounding ; Vyas_2020_Hidden . The paradox of pneumonia risk prediction starkly illustrates this brittleness: models learnt to classify asthma patients as lower risk because they received aggressive early treatment in training hospitals, which could lead to dangerous under-treatment when deployed elsewhere Caruana_2015_Intelligible . The question facing healthcare AI is no longer whether systems can achieve impressive accuracy in retrospective test sets, but whether they can survive clinical deployment across diverse institutions, populations, and practice patterns and maintain both effectiveness and equity. This brittleness stems from a fundamental mismatch between what machine learning optimises and what healthcare requires. Clinical decisions inherently require understanding causal mechanisms, will this drug help this patient? Would this patient have developed complications under alternative treatment?, yet current models learn statistical associations that may reflect institutional practices, equipment characteristics, patient selection, or confounding variables rather than biological reality Castro_2020_Causality ; Richens_2020_Improving . The COVID-19 pandemic exposed these limitations with devastating clarity, where predictive models trained on historical data failed catastrophically when confronted with a novel pathogen and rapidly evolving clinical practices, highlighting the urgent need for methods that generalise based on causal invariance rather than statistical regularities Wynants_2020_Prediction ; Roberts_2021_Common . The consequences extend beyond accuracy metrics to patient harm, as models that encode spurious correlations can recommend interventions effective in training environments but ineffective or harmful in deployment settings. Moreover, mounting evidence demonstrates that AI systems trained on historical data perpetuate or amplify existing healthcare disparities, with purely statistical fairness metrics proving insufficient to address discrimination transmitted along causal pathways Kilbertus_2017_Avoiding ; Kusner_2017_Counterfactual ; Plecko_2024_Causal_Fairness ; AdamsPrassl_2023_Algorithmic . The distinction between correlation and causation maps directly to Pearl’s Causal Hierarchy, which organises reasoning into three levels of increasing inferential power Pearl_2009_Causality ; Hernan_2020_Causal . Level 1 (Association) addresses observational queries through conditional probabilities P(Y|X) , answering “what is?” questions via pattern recognition, the domain where standard machine learning excels. Level 2 (Intervention) concerns the effects of actions, formalised using the do-operator P(Y|\text{do}(X)) , addressing “what if we do?” questions essential for treatment planning. Level 3 (Counterfactual) queries alternative outcomes under hypothetical conditions, answering “what would have been?” questions critical for personalised medicine and retrospective analysis. Healthcare demands information at Levels 2 and 3, predicting treatment responses, comparing therapeutic strategies, and identifying causal disease mechanisms, yet standard models operate solely at Level 1, identifying statistical patterns without understanding the causal structure Prosperi_2020_Nmi . The Causal Hierarchy Theorem demonstrates that these levels form a strict hierarchy where information at higher levels cannot be derived from lower levels without additional causal assumptions Pearl_2009_Causality . This fundamental limitation explains why purely associational machine learning models, regardless of architectural sophistication or scale of training data, fail to answer interventional and counterfactual questions essential for robust clinical decision-making. Biomedical systems naturally form networks, molecular interactions, brain connectivity, metabolic pathways, protein complexes, and disease comorbidity patterns, making graph representations the natural framework for encoding biological relationships Barabasi_2011_Network ; Nicholson_2023_Constructing . Graph neural networks extend traditional graph analysis beyond fixed topological measures by learning representations directly from graph-structured data through iterative message passing, where nodes aggregate information from neighbours via learnable neural transformations that capture both local motifs and global network properties Hamilton_2020_Graph ; Battaglia_2018_Relational ; Kipf_2017_Semi . This learning paradigm has demonstrated substantial advantages over handcrafted graph features in biomedical applications, from molecular property prediction on chemical graphs to psychiatric diagnosis from brain connectivity networks Duvenaud_2015_Convolutional ; Ktena_2018_Metric ; Stokes_2020_Deep . Yet standard GNNs inherit supervised learning’s fundamental limitation: they optimise predictive performance by exploiting any statistical pattern in training data, whether reflecting genuine biological mechanisms or spurious correlations from confounding, selection bias, or batch effects, treating all network edges equally regardless of underlying causal structure Bevilacqua_2021_Size ; Knyazev_2019_Understanding . The convergence of causal inference with graph neural networks addresses this challenge. Yet, standard GNNs inherit and amplify the correlation-causation conflation, learning to exploit whatever statistical patterns maximise performance regardless of biological plausibility or causal validity Bevilacqua_2021_Size ; Knyazev_2019_Understanding . Recent theoretical advances in causal representation learning provide a path forward. By explicitly modelling causal structures within graph architectures, we can develop models that identify genuine therapeutic targets, predict treatment responses under interventions never observed in training data, and discover disease mechanisms rather than spurious correlations Scholkopf_2021_Toward ; Locatello_2020_Commentary . This convergence is particularly timely given the four concurrent developments. First, the accumulation of multi-modal biomedical data, from single-cell sequencing that captures 20,000+ gene expression profiles to continuous physiological monitoring that generates terabytes of temporal dynamics, provides unprecedented resolution for causal discovery. Datasets now capture interventional outcomes and temporal dependencies that were previously unavailable Regev_2017_Human ; Topol_2019_High ; conroy2023uk . Second, regulatory frameworks increasingly demand explainable AI in healthcare, which requires not merely predictions, but a mechanistic understanding that clinicians can verify against domain expertise and biological knowledge FDA_2021_AI ; Murdoch_2021_Definitions . Third, documented

Read the complete text